- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
A Look at the Neural Fair Value Portfolio for Investment Ideas
-
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
-
Amgen's Better than Expected Portfolio Outlook
-
15 Stocks with the Stamina to Survive This Crisis
-
FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM
-
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
-
Hedge Fund Eton Park Saw Golden Opportunities in Q109
-
Inspire Pharma Still Looks Good After Earnings
-
20 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
-
FDA Calendar Updates: Botox Rival Approved
-
Preview from Europe: Stocks Encounter Car Trouble
-
Thursday Options Recap
-
Thursday Options Update: VMW, FXI, AGN, WYE, XRT & COH
-
Paired Trade: Sell Allergan, Buy Johnson & Johnson
-
Updated FDA, Clinical Trial Calendars: Dendreon Releases Results
-
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
-
Morphosys: A Biotech Rule Breaker (Part 2)
-
Tuesday Options Update: Q, AGN, VIX, LTD, XHB, SYK, IP & TGT
-
Monday Options Update: XLF, JPM, C, AGN, RHT, SU, SWY
-
Earnings Preview: Allergan
-
Cynosure Has Weak Q4, Sparking Possibilities of Takeover
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
-
Updated FDA Decision Calendar: Five Decisions Before Year-End
-
Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008
-
Johnson & Johnson Steals Mentor Corp.: Who's Next?
-
Weekly FDA Calendar Update
-
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
-
Earnings Preview: Allergan
-
Friday Options Update: MSFT, HBC, DWA, AGN, XLF, C, MS and VIX
-
Industry Profile: Cosmetic and Reconstructive Medicine
-
Summer Surge for Pharma Powers IHE, but Concerns Remain
-
Allergan: When Deals Get Ugly
-
Earnings Preview: Allergan
-
Roche and Allergan Victorious Over Apotex in Acular LS Dispute
-
Credit Suisse Healthier 15: Investors Get the Skinny on Fat Fighters
-
Will Wal-Mart Heat Up Chile? Fast Money (6/17/08)
-
Wrinkle in Allergan’s Forecast
-
Pfizer Should Buy Amgen or Wyeth - Credit Suisse
-
Wall Street Breakfast: Must-Know News
-
Allergan Drops Unnecessarily on FDA BOTOX Review
-
7 Healthcare Stocks for a Sick Market